Prof. Xiansheng Liu | Charismatic Leadership | Best Scholar Award

Prof. Xiansheng Liu , Charismatic Leadership, Best Scholar Award

Prof. Xiansheng Liu, Shanxi Bethune Hospital China

๐Ÿ”— Professional Profiles

Summary ๐ŸŒŸ

Dr. Liu Xiansheng is a distinguished professor and chief physician with a notable career in respiratory medicine. Currently serving as the President and Deputy Secretary of Shanxi Bethune Hospital, he has significantly contributed to the field through both his clinical practice and research. He has published over 120 papers and led numerous significant research projects, earning prestigious awards for his scientific achievements.

Education ๐ŸŽ“

  • Ph.D. in Respiratory Medicine
    Tongji Medical College, Huazhong University of Science and Technology (09/1999 – 07/2002)
  • Master’s in Respiratory Medicine
    Original Tongji Medical University (09/1995 – 07/1998)
  • Bachelor’s in Clinical Medicine
    Original Tongji Medical University (09/1987 – 07/1992)

Professional Experience ๐Ÿ’ผ

  • President and Deputy Secretary
    Shanxi Bethune Hospital (01/2019 – Present)
  • Professor / Chief Physician
    Tongji Hospital, Huazhong University of Science and Technology (06/2002 – Present)
  • Postdoctoral Fellow
    Virginia Commonwealth University School of Medicine, USA (06/2005 – 12/2006)
  • Resident Physician
    Tongji Hospital, Huazhong University of Science and Technology (09/1992 – 07/1995)

Research Interests ๐Ÿ”ฌ

Dr. Liu specializes in both basic and clinical research related to asthma and chronic obstructive pulmonary disease (COPD). His work has led to several advancements in these fields, supported by various high-profile grants and projects. His research contributions have been recognized with multiple awards, including national and provincial prizes for science and technology progress.

Publication Top Noted

Exosome microRNA-125a-5p derived from epithelium promotes M1 macrophage polarization by targeting IL1RN in chronic obstructive pulmonary disease

    • Authors: Wang, R., Zhu, Z., Peng, S., Wei, S., Liu, X.
    • Journal: International Immunopharmacology
    • Year: 2024
    • Volume: 137
    • Issue: –
    • Pages: 112466

COPD patients with high blood eosinophil counts exhibit a lower rate of omicron infection and milder post-infection symptoms

    • Authors: Bai, X., Niu, Y., Wei, S., Liu, X., Wang, R.
    • Journal: Clinical Respiratory Journal
    • Year: 2024
    • Volume: 18
    • Issue: 6
    • Pages: e13790

Secular trends of asthma mortality in China and the United States from 1990 to 2019

    • Authors: Li, X., Guo, M., Niu, Y., Xie, M., Liu, X.
    • Journal: Chinese Medical Journal
    • Year: 2024
    • Volume: 137
    • Issue: 3
    • Pages: 273-282

Identification of novel biomarkers related to neutrophilic inflammation in COPD

    • Authors: Huang, Y., Niu, Y., Wang, X., He, Y., Liu, X.
    • Journal: Frontiers in Immunology
    • Year: 2024
    • Volume: 15
    • Issue: –
    • Pages: 1410158

Effect of fracture risk in inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

    • Authors: Peng, S., Tan, C., Du, L., Liu, X., Wang, R.
    • Journal: BMC Pulmonary Medicine
    • Year: 2023
    • Volume: 23
    • Issue: 1
    • Pages: 304
  • ย